HAYWARD, Calif. -- (BUSINESS WIRE) -- Pharmatech Associates, a regulatory compliance consultancy serving companies in the pharmaceutical, biotech and medical device industries, will lead training sessions on Quality by Design (QbD) and the new Process Validation (PV) requirements at the 2013 ISPE Australasian Conference taking place September 9-11 in Canberra, Australia.
Pharmatech executives Bikash Chatterjee, President and CTO, and Wai Wong, Vice President and General Manager of Worldwide Operations, will address the new quality paradigm that comprises QbD and PV in a case study workshop demonstrating the benefits of these regulatory concepts and an approach for their practical application.
The ISPE Australasian Conference features presentations by leading global industry experts and local practitioners in a program titled “Where Global Knowledge Meets Local Experience” to give professionals and local TGA regulatory authorities a better understanding of the industry's current technical and regulatory challenges and an opportunity to engage in open dialogue.
ISPE is the world’s largest not-for-profit society serving pharmaceutical and medical device, engineering, science and manufacturing professionals.
About Pharmatech Associates
Pharmatech Associates (founded in 1995) consults to the pharmaceutical, biotech, medical device manufacturing and other regulated life sciences industries. Headquartered in the San Francisco Bay Area, Pharmatech advises clients that range in size from startups to large multi-national corporations on projects in North America, Asia and Europe.